NCT01919827 Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT01890265 Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT01874223 Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF Status COMPLETED Phase N/A
NCT01872689 A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT01809574 The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease Status UNKNOWN Phase N/A
NCT01777737 Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole Status TERMINATED Phase PHASE3
NCT01772667 Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis Status COMPLETED Phase NA
NCT01769196 Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01766817 Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT01759511 Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01738711 Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients Status UNKNOWN Phase NA
NCT01725139 A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1
NCT01714934 The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase N/A
NCT01695408 Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT01637831 CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea Status COMPLETED Phase NA
NCT01629667 A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT01619085 Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3